Xiangyu Li

Dr. Xiangyu Li

Science for Life Laboratory
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
MKMax Karlsson
Max Karlsson
CZCheng Zhang
Cheng Zhang
LMLoren Méar
Loren Méar
WZWen Zhong
Wen Zhong
ADAndreas Digre
Andreas Digre
CLCecilia Lindskog
Cecilia Lindskog
Single-cell RNA analysis has been integrated with spatial protein profiling to create a single–cell type map of human tissues.

5 September 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
HJHan Jin
Han Jin
CZCheng Zhang
Cheng Zhang
MZMartin Zwahlen
Martin Zwahlen
KFKalle von Feilitzen
Kalle von Feilitzen
MKMax Karlsson
Max Karlsson
AMAdil Mardinoglu
Adil Mardinoglu
Cell lines are valuable resources as model for human biology and translational medicine. It is thus important to explore the concordance between the expression in various cell lines vis-à-vis human native and disease tissues. In this study, we investigate the expression of all human protein-coding genes in more than 1,000 human cell lines representing 27 cancer types by a genome-wide transcriptomics analysis. The cell line gene expression is compared with the corresponding profiles in various tissues, organs, single-cell types and cancers. Here, we present the expression for each cell line and give guidance for the most appropriate cell line for a given experimental study. In addition, we explore the cancer-related pathway and cytokine activity of the cell lines to aid human biology studies and drug development projects. All data are presented in an open access cell line section of the Human Protein Atlas to facilitate the exploration of all human protein-coding genes across these cell lines.

22 August 2022 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
RBRitesh K. Baboota
Ritesh K. Baboota
ARAidin Rawshani
Aidin Rawshani
LBLaurianne Bonnet
Laurianne Bonnet
XLXiangyu Li
Xiangyu Li
HYHong Yang
Hong Yang
USUlf Smith
Ulf Smith
The role of hepatic cell senescence in human non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is not well understood. To examine this, we performed liver biopsies and extensive characterization of 58 individuals with or without NAFLD/NASH. Here, we show that hepatic cell senescence is strongly related to NAFLD/NASH severity, and machine learning analysis identified senescence markers, the BMP4 inhibitor Gremlin 1 in liver and visceral fat, and the amount of visceral adipose tissue as strong predictors. Studies in liver cell spheroids made from human stellate and hepatocyte cells show BMP4 to be anti-senescent, anti-steatotic, anti-inflammatory and anti-fibrotic, whereas Gremlin 1, which is particularly highly expressed in visceral fat in humans, is pro-senescent and antagonistic to BMP4. Both senescence and anti-senescence factors target the YAP/TAZ pathway, making this a likely regulator of senescence and its effects. We conclude that senescence is an important driver of human NAFLD/NASH and that BMP4 and Gremlin 1 are novel therapeutic targets.

13 September 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
QGQingzhou Guan
Qingzhou Guan
RCRou Chen
Rou Chen
HYHaidan Yan
Haidan Yan
HCHao Cai
Hao Cai
YGYou Guo
You Guo
ZGZheng Guo
Zheng Guo
Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms

27 February 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
JCJun Cheng
Jun Cheng
YGYou Guo
You Guo
QGQiao Gao
Qiao Gao
HLHongdong Li
Hongdong Li
HYHaidan Yan
Haidan Yan
ZGZheng Guo
Zheng Guo
Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites

1 January 2018 in International Journal of Biological Sciences
Verified
Journal Article
Open access
HCHao Cai
Hao Cai
XLXiangyu Li
Xiangyu Li
JLJing Li
Jing Li
QLQirui Liang
Qirui Liang
WZWeicheng Zheng
Weicheng Zheng
XWXianlong Wang
Xianlong Wang
It is a basic task in high-throughput gene expression profiling studies to identify differentially expressed genes (DEGs) between two phenotypes. But the weakly differential expression signals between two phenotypes are hardly detectable with limited sample sizes. To solve this problem, many researchers tried to combine multiple independent datasets using meta-analysis or batch effect adjustment algorithms. However, these algorithms may distort true biological differences between two phenotypes and introduce unacceptable high false rates, as demonstrated in this study. These problems pose critical obstacles for analyzing the transcriptional data in The Cancer Genome Atlas where there are many small-scale batches of data. Previously, we developed RankComp to detect DEGs for individual disease samples through exploiting the incongruous relative expression orderings between two phenotypes and further improved it here to identify DEGs using multiple independent datasets. We demonstrated the improved RankComp can directly analyze integrated cross-site data to detect DEGs between two phenotypes without the need of batch effect adjustments. Its usage was illustrated in detecting weak differential expression signals of breast cancer drug-response data using combined datasets from multiple experiments.